<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: tb control</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Massive funding boost needed to beat TB, UN says (Update)</title>
   	 <description>The global fight against tuberculosis needs a massive financial boost as drug-resistant strains of the disease take hold, two international organisations warned on Monday.</description>
     <link>http://medicalxpress.com/news/2013-03-massive-funding-boost-tb.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 18 Mar 2013 09:50:02 EST</pubDate>
	 <guid isPermaLink="false">news282818004</guid>
	 
</item>
<item>
     <title>Little evidence to support TB interventions in real-world, low-resource settings</title>
   	 <description>There is little evidence from real world situations in low-and-middle income countries to support the effectiveness and financial value of five interventions* recommended by the World Health Organization (WHO) to control tuberculosis, which may be a reason why these interventions have not been implemented in many countries, according to a study by international experts published in this week's PLOS Medicine.</description>
     <link>http://medicalxpress.com/news/2012-12-evidence-tb-interventions-real-world-low-resource.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 18 Dec 2012 17:00:42 EST</pubDate>
	 <guid isPermaLink="false">news275072428</guid>
	 
</item>
<item>
     <title>New test for tuberculosis could improve treatment, prevent deaths in Southern Africa</title>
   	 <description>A new rapid test for tuberculosis (TB) could substantially and cost-effectively reduce TB deaths and improve treatment in southern Africa—a region where both HIV and tuberculosis are common—according to a new study by Harvard School of Public researchers.</description>
     <link>http://medicalxpress.com/news/2012-11-tuberculosis-treatment-deaths-southern-africa.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 20 Nov 2012 17:00:14 EST</pubDate>
	 <guid isPermaLink="false">news272647668</guid>
	 
</item>
<item>
     <title>Tuberculosis's genetic 'family tree' may hold the key to tackling outbreaks quickly and effectively</title>
   	 <description>Researchers, led by the NIHR Oxford Biomedical Research Centre, the Health Protection Agency in Birmingham and the Wellcome Trust Sanger Institute in Cambridge, have pioneered the whole genome sequencing (WGS) method through a study of 254 TB cases in the Midlands.</description>
     <link>http://medicalxpress.com/news/2012-11-tuberculosis-genetic-family-tree-key.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 14 Nov 2012 18:30:05 EST</pubDate>
	 <guid isPermaLink="false">news272129666</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-tuberculosis.jpg" width="90" height="90" />
</item>
<item>
     <title>India wages hi-tech war on ancient TB scourge</title>
   	 <description>(AP)—Shammo Khan walks into a dusty courtyard that reeks of garbage, searching for the fingerprint of a man exhausted by HIV, drug withdrawal and the tuberculosis lesions hijacking his lungs.</description>
     <link>http://medicalxpress.com/news/2012-11-india-wages-hi-tech-war-ancient.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 11 Nov 2012 14:52:17 EST</pubDate>
	 <guid isPermaLink="false">news271867926</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/indiawageshi.jpg" width="90" height="90" />
</item>
<item>
     <title>International study reveals alarming levels of extensively drug-resistant tuberculosis</title>
   	 <description>A large, international study published Online First in The Lancet reveals alarming levels of tuberculosis (TB) that are resistant to both first-line and second-line drugs. The findings show high prevalence of resistance to at least one second-line drug (43.7%) among multidrug-resistant (MDR) TB patients from eight countries in Africa, Asia, Europe, and Latin America. Worse still, the study found higher than expected overall levels of extensively drug-resistant (XDR) TB.</description>
     <link>http://medicalxpress.com/news/2012-08-international-reveals-alarming-extensively-drug-resistant.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 29 Aug 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news265479566</guid>
	 
</item>
<item>
     <title>Targeting tuberculosis 'hotspots' could have widespread benefit: study</title>
   	 <description>Reducing tuberculosis transmission in geographic &quot;hotspots&quot; where infections are highest could significantly reduce TB transmission on a broader scale, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. An analysis of data from Rio de Janeiro showed that a reduction in TB infections within three high-transmission hotspots could reduce citywide transmission by 9.8 percent over 5 years, and as much as 29 percent over 50 years. The study was published May 28 by the journal PNAS.</description>
     <link>http://medicalxpress.com/news/2012-05-tuberculosis-hotspots-widespread-benefit.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 28 May 2012 15:00:18 EST</pubDate>
	 <guid isPermaLink="false">news257415377</guid>
	 
</item>
<item>
     <title>U.S. tuberculosis cases hit record low, CDC says</title>
   	 <description>(HealthDay) -- Tuberculosis rates fell to an all-time low in the United States in 2011, but the disease continues to disproportionately infect racial and ethnic minorities, those who are foreign-born and people infected with HIV, federal officials reported Thursday.</description>
     <link>http://medicalxpress.com/news/2012-03-tuberculosis-cases-cdc.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 22 Mar 2012 15:58:08 EST</pubDate>
	 <guid isPermaLink="false">news251650621</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ustuberculos.jpg" width="90" height="90" />
</item>
<item>
     <title>NIH researchers highlight progress, path forward for developing TB vaccines</title>
   	 <description>In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the way for the next 10 years of research on TB vaccines, a critical component of TB control efforts, note scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Their editorial, co-authored by NIAID Director Anthony S. Fauci, M.D., and Christine Sizemore, Ph.D., appears in the journal Tuberculosis to coincide with the publication of Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade.</description>
     <link>http://medicalxpress.com/news/2012-03-nih-highlight-path-tb-vaccines.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 20 Mar 2012 05:56:10 EST</pubDate>
	 <guid isPermaLink="false">news251441752</guid>
	 
</item>
<item>
     <title>New tuberculosis research movement needed</title>
   	 <description>In this week's PLoS Medicine, Christian Lienhardt from the WHO in Geneva, Switzerland and colleagues announce that the Stop TB Partnership and the WHO Stop TB Department have launched the TB Research Movement.</description>
     <link>http://medicalxpress.com/news/2011-11-tuberculosis-movement.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 30 Nov 2011 02:36:53 EST</pubDate>
	 <guid isPermaLink="false">news241843000</guid>
	 
</item>
<item>
     <title>Decrease in observed rate of TB at a time of economic recession</title>
   	 <description>The incidence of tuberculosis (TB) in the U.S. is reported as being on the decrease, however untreated infected people act as a reservoir for disease. Any pool of the world's population harboring this disease gives cause for concern, especially since the BCG vaccine is only 70-80% effective at best. New research published in BioMed Central's open access journal BMC Public Health, shows that in 2009 the number of cases of TB reported across America was much lower than that recorded in previous years. This larger than expected decrease was most noticeable among recent immigrants, the homeless and other disadvantaged groups, which suggested that the decrease was most likely due to economic recession and lower immigration rates and may mask the future impact of TB.</description>
     <link>http://medicalxpress.com/news/2011-11-decrease-tb-economic-recession.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 07 Nov 2011 04:05:29 EST</pubDate>
	 <guid isPermaLink="false">news239861055</guid>
	 
</item>
<item>
     <title>Diabetics at higher risk of tuberculosis infection, researchers find</title>
   	 <description>People with diabetes have a three to five times higher risk of contracting tuberculosis (TB) than non-diabetics, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).</description>
     <link>http://medicalxpress.com/news/2011-05-diabetics-higher-tuberculosis-infection.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 24 May 2011 09:15:45 EST</pubDate>
	 <guid isPermaLink="false">news225447326</guid>
	 
</item>


</channel>
</rss>
